1.2Peptide release from pores
A porous hydrogel contains a soluble triple-helical collagen-mimetic peptide in its aqueous phase. The peptide diffuses out of the gel and binds discoidin domain receptors on nearby cells.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A porous hydrogel contains a soluble triple-helical collagen-mimetic peptide in its aqueous phase. The peptide diffuses out of the gel and binds discoidin domain receptors on nearby cells.
Amide bonds couple hyaluronan carboxyl groups to primary amines on the base surface. Surface-bound hyaluronan engages CD44 on cells that express the receptor and supports their attachment.
A flexible spacer presents an arginine-glycine-aspartate peptide motif above the surface. Integrins such as αvβ3 bind the exposed motif and connect the adhesion site to the actin cytoskeleton.
A terminal anchor tethers a lysine- and arginine-rich peptide to the base and exposes its basic residues. The positively charged residues interact with sulfate groups on cell-surface proteoglycans and help retain contacting cells.
A molded polymer surface contains recessed cavities with openings wide enough to admit cells during seeding. Cells settle into the cavities, where the walls shelter them from direct fluid shear during perfusion.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A removable borosilicate glass insert carries a surface-tethered, triple-helical collagen-mimetic peptide with a discoidin domain receptor binding motif. A culture vessel holds the insert below the medium surface and supports bovine muscle progenitor cells on the functionalized face. The tether presents the binding motif to cell-surface receptors during culture, and the insert lifts out for cell imaging or harvest.
A sintered titanium disk provides an interconnected pore network and a surface oxide for peptide attachment. A phosphonate anchor binds to the oxide and connects a discoidin domain receptor binding peptide to the pore walls through a flexible spacer. The disk is immersed during coating so the coupling solution reaches the internal surfaces, where the tethered peptide contacts cells that enter the pores.
A removable microfluidic stencil defines parallel stripes with widths of 25, 100, and 400 micrometers on a functionalized glass slide. Each channel receives the same solution of discoidin domain receptor binding peptide, which couples to the exposed glass through a terminal attachment group. After stencil removal, a cell culture covers the slide and fluorescence microscopy records receptor phosphorylation at stripe centers and edges.
Silica microspheres with nominal diameters of 100, 200, and 300 micrometers serve as separate culture substrates. A surface silane and a flexible spacer tether the same discoidin domain receptor binding peptide to each bead size. Cells attach to the coated beads in separate stirred culture vessels, and microscopy records cell coverage and receptor phosphorylation by bead diameter.
A peptide-coated glass coverslip forms the floor of a gasket-sealed parallel-plate perfusion chamber. Cells attach to the coverslip, where the tethered peptide engages discoidin domain receptors at the cell-facing surface. A syringe pump supplies culture medium through the channel, and an inverted microscope images the cells through the coverslip during perfusion.
A robotic liquid handler dispenses a dilution series of discoidin domain receptor binding peptide into a glass-bottom multiwell plate with reactive surfaces. The peptide couples to each well through a terminal attachment group, and an automated microscope records surface fluorescence from a fixed fraction of labeled peptide to estimate relative coating density. After cell seeding and staining, image analysis measures phosphorylated receptor signal per cell and plots it against the measured surface density.
Cells grow to confluence on a temperature-responsive culture surface and deposit extracellular matrix between neighboring cells. Cooling releases the intact sheet, and its retained matrix provides cohesion during transfer.
Laser powder-bed fusion forms a titanium alloy lattice with interconnected pores. An oxide layer covers the lattice struts and provides a surface for peptide coupling.
Electrospinning deposits polycaprolactone microfibers as a porous mat. Mild alkaline hydrolysis creates surface carboxyl groups for coupling to peptide amines.
A phosphonate-terminated spacer anchors to the titanium oxide surface and couples to the terminus of a collagen-mimetic peptide. Glycine-proline-hydroxyproline repeats stabilize the triple helix, which presents a glycine-valine-methionine-glycine-phenylalanine-hydroxyproline motif for discoidin domain receptor binding.
Maleimide groups at the surface of a polyethylene glycol hydrogel react with a terminal cysteine on a triple-helical collagen-mimetic peptide. A flexible spacer between the cysteine and the helix exposes the receptor-binding motif to discoidin domain receptors on contacting cells.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
Accordingly, in one embodiment the invention relates to a cell culture system comprising a biomaterial substrate comprising at least a first linear surface gradient oriented orthogonally to a second linear surface gradient (i.e. two linear gradients oriented under a 90° angle), wherein said first gradient and said second gradient are selected from the group consisting of stiffness (S), aligned topography (T) and wettability (W).B · US 2021/0130770 A1 · ¶ 11
DDRs are activated by a number of triple-helical collagens, which are the most abundant components of the extracellular matrix (ECM).A · US 2020/0030332 A1 · ¶ 2
Once inserted into a biological environment, proteins adsorb or not to the biomaterials' surface promoting or not the adhesion of cells as embodied by the long-known process of adhesion mediated by integrins and RGD motifs [5].B · US 2021/0130770 A1 · ¶ 5
An empty cell means only that no passage was reproduced there.
At present, there are no pharmacological agents capable of effectively treating joint diseases (in particular degenerative arthritis).A · US 2020/0030332 A1 · ¶ 3
DDR1 is currently known to play an important role in bone development, but the relevant mechanisms of DDR1 in bone development and cartilage development remain unclear.A · US 2020/0030332 A1 · ¶ 4
The present inventors therefore set out to develop a novel biomaterial approach that allow for the pre-screening of combined surface parameters, thereby greatly facilitating the clinical translation of biomaterials.B · US 2021/0130770 A1 · ¶ 8
In particular, they aimed at providing a novel platform that can be coupled to high throughput analysis capabilities and offering the possibility to integrate it into established commercial systems, thus making the technology broadly accessible and applicable.B · US 2021/0130770 A1 · ¶ 8
patent.fyi, US 2026/0355386 A1, claim 1, first published 2026-11-19T10:59:45-05:00, https://patent.fyi/US20260355386/, SHA-256 6305780c3ac39b16eeb2481f695dc1e219881bbe4cb91e54bf67677a288da0bb